FdaApplication

ANDA 202136

Back to search

Identifiers

Properties

PropertyValue
applicant_nameMYLAN PHARMACEUTICALS INC
application_typeANDA
approval_date2025-07-22

Products (5)

ProductActive ingredientStrengthDosage form
DARUNAVIRDARUNAVIR600MGTABLET;ORAL
DARUNAVIRDARUNAVIR150MGTABLET;ORAL
DARUNAVIRDARUNAVIR300MGTABLET;ORAL
DARUNAVIRDARUNAVIR75MGTABLET;ORAL
DARUNAVIRDARUNAVIR400MGTABLET;ORAL

5 products